Welcome to the BSACI Registry for Immunotherapy (BRIT)
BRIT is a prospective web based patient registry that records immunotherapy treatment of patients under the care of BSACI consultants practicing in the UK.
Immunotherapy is a form of specialised treatment that can harness the immune system to reduce symptoms of a wide range of allergic and non-allergic diseases.
There are several forms of immune based therapy routinely used by allergists in the UK.
BRIT was established in 2018, by a collaboration of adult and paediatric allergists in the UK, to record the use of these treatments, their effectiveness in treating severe allergic disease and to monitor side effects in routine practice.
- Allergen Immunotherapy (AIT) by both subcutaneous and sublingual immunotherapy routes (also known as SCIT and SLIT)
- Venom immunotherapy (VIT)
- The use of the monoclonal antibody Omalizumab (OMA) for Chronic Spontaneous Urticaria (CSU).